{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:19:25Z","timestamp":1788383965233,"version":"build-2803163510"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T00:00:00Z","timestamp":1588809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T00:00:00Z","timestamp":1588809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s13346-020-00770-z","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T00:03:03Z","timestamp":1588809783000},"page":"1095-1110","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Nanobiotechnological modules as molecular target tracker for the treatment and prevention of malaria: options and opportunity"],"prefix":"10.1007","volume":"10","author":[{"given":"Jain","family":"Anamika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishwakarma","family":"Nikhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Laxmikant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrivastava","family":"Priya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vyas","family":"Sonal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8388-8321","authenticated-orcid":false,"given":"S. P.","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,7]]},"reference":[{"issue":"10","key":"770_CR1","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.3390\/molecules23102527","volume":"23","author":"Z Mhlwatika","year":"2018","unstructured":"Mhlwatika Z, Aderibigbe BA. Polymeric nanocarriers for the delivery of antimalarials. Molecules. 2018;23(10):2527.","journal-title":"Molecules."},{"key":"770_CR2","doi-asserted-by":"crossref","unstructured":"Margaret A, Phillips JNB, Christine Manyando, van Huijsduijnen Rob Hooft, Van Voorhis Wesley C, Timothy N. C. Wells Malaria. NATURE REVIEWS | DISEASE PRIMERS 2017;3.","DOI":"10.1038\/nrdp.2017.50"},{"issue":"6","key":"770_CR3","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrd1416","volume":"3","author":"DA Fidock","year":"2004","unstructured":"Fidock DA, Rosenthal PJ, Croft SL, Brun R, Nwaka S. Antimalarial drug discovery: efficacy models for compound screening. Nat Rev Drug Discov. 2004;3(6):509\u201320.","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"770_CR4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/1061186X.2017.1291645","volume":"25","author":"UK Baruah","year":"2017","unstructured":"Baruah UK, Gowthamarajan K, Vanka R, Karri VVSR, Selvaraj K, Jojo GM. Malaria treatment using novel nano-based drug delivery systems. J Drug Target. 2017;25(7):567\u201381.","journal-title":"J Drug Target"},{"key":"770_CR5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fphar.2015.00091","volume":"6","author":"K Basore","year":"2015","unstructured":"Basore K, Cheng Y, Kushwaha AK, Nguyen ST, Desai SA. How do antimalarial drugs reach their intracellular targets? Front Pharmacol. 2015;6:91.","journal-title":"Front Pharmacol"},{"key":"770_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/3702518","volume":"2019","author":"D Lombardo","year":"2019","unstructured":"Lombardo D, Kiselev MA, Caccamo MT. Smart nanoparticles for drug delivery application: development of versatile nanocarrier platforms in biotechnology and nanomedicine. J Nanomater. 2019;2019:1\u201326.","journal-title":"J Nanomater"},{"issue":"4\u20135","key":"770_CR7","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.addr.2009.11.024","volume":"62","author":"NS Santos-Magalh\u00e3es","year":"2010","unstructured":"Santos-Magalh\u00e3es NS, Mosqueira VCF. Nanotechnology applied to the treatment of malaria. Adv Drug Deliv Rev. 2010;62(4\u20135):560\u201375.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"770_CR8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1152\/physrev.2001.81.2.495","volume":"81","author":"K Kirk","year":"2001","unstructured":"Kirk K. Membrane transport in the malaria-infected erythrocyte. Physiol Rev. 2001;81(2):495\u2013537.","journal-title":"Physiol Rev"},{"key":"770_CR9","doi-asserted-by":"crossref","unstructured":"Najer A, Palivan CG, Beck H-P, Meier W. Challenges in malaria management and a glimpse at some nanotechnological approaches. In: Infectious Diseases and Nanomedicine III: Springer; 2018; 1052:103\u201312.","DOI":"10.1007\/978-981-10-7572-8_9"},{"key":"770_CR10","volume-title":"An overview of application of nanotechnology in malaria control","author":"D Pam","year":"2017","unstructured":"Pam D, Omalu I, Innalegwu D, Opemipo B, Hassan F, Kasim J, et al. An overview of application of nanotechnology in malaria control. 2017."},{"issue":"2","key":"770_CR11","first-page":"37","volume":"9","author":"RR Wakaskar","year":"2017","unstructured":"Wakaskar RR. Passive and active targeting in tumor microenvironment. Int J Drug Dev Res. 2017;9(2):37\u201341.","journal-title":"Int J Drug Dev Res"},{"issue":"5","key":"770_CR12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2165\/00063030-200822050-00004","volume":"22","author":"FM Veronese","year":"2008","unstructured":"Veronese FM, Mero A. The impact of PEGylation on biological therapies. BioDrugs. 2008;22(5):315\u201329.","journal-title":"BioDrugs."},{"issue":"28","key":"770_CR13","doi-asserted-by":"crossref","first-page":"13773","DOI":"10.1039\/C8NR02442A","volume":"10","author":"M Raza","year":"2018","unstructured":"Raza M, Bharti H, Singal A, Nag A, Ghosh PC. Long circulatory liposomal maduramicin inhibits the growth of Plasmodium falciparum blood stages in culture and cures murine models of experimental malaria. Nanoscale. 2018;10(28):13773\u201391.","journal-title":"Nanoscale."},{"issue":"3","key":"770_CR14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/08982104.2010.539185","volume":"21","author":"B Isacchi","year":"2011","unstructured":"Isacchi B, Arrigucci S, Marca G, Bergonzi MC, Vannucchi MG, Novelli A, et al. Conventional and long-circulating liposomes of artemisinin: preparation, characterization, and pharmacokinetic profile in mice. J Liposome Res. 2011;21(3):237\u201344.","journal-title":"J Liposome Res"},{"issue":"6","key":"770_CR15","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1248\/bpb.b16-00914","volume":"40","author":"S Ibrahim","year":"2017","unstructured":"Ibrahim S, Tagami T, Ozeki T. Effective-loading of platinum\u2013chloroquine into PEGylated neutral and cationic liposomes as a drug delivery system for resistant malaria parasites. Biol Pharm Bull. 2017;40(6):815\u201323.","journal-title":"Biol Pharm Bull"},{"key":"770_CR16","unstructured":"Li S, Meng Q, Mao J, Li J, Xu A, Liu J, et al Pegylated artesunate derivative, pharmaceutical composition and use thereof. Google Patents; 2017."},{"issue":"2","key":"770_CR17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2174\/1872208313666181204095314","volume":"13","author":"CE Umeyor","year":"2019","unstructured":"Umeyor CE, Obachie O, Chukwuka R, Attama A. Development insights of surface modified lipid nanoemulsions of dihydroartemisinin for malaria chemotherapy: characterization, and in vivo antimalarial evaluation. Recent Pat Biotechnol. 2019;13(2):149\u201365.","journal-title":"Recent Pat Biotechnol"},{"issue":"3","key":"770_CR18","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1128\/AAC.01796-15","volume":"60","author":"V Rajendran","year":"2016","unstructured":"Rajendran V, Rohra S, Raza M, Hasan GM, Dutt S, Ghosh PC. Stearylamine liposomal delivery of monensin in combination with free artemisinin eliminates blood stages of Plasmodium falciparum in culture and P. berghei infection in murine malaria. Antimicrob Agents Chemother. 2016;60(3):1304\u201318.","journal-title":"Antimicrob Agents Chemother"},{"key":"770_CR19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijpharm.2019.03.031","volume":"562","author":"M Ismail","year":"2019","unstructured":"Ismail M, Du Y, Ling L, Li X. Artesunate-heparin conjugate based nanocapsules with improved pharmacokinetics to combat malaria. Int J Pharm. 2019;562:162\u201371.","journal-title":"Int J Pharm"},{"issue":"9","key":"770_CR20","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1002\/jps.24428","volume":"104","author":"H Mizusako","year":"2015","unstructured":"Mizusako H, Tagami T, Hattori K, Ozeki T. Active drug targeting of a folate-based cyclodextrin\u2013doxorubicin conjugate and the cytotoxic effect on drug-resistant mammary tumor cells in vitro. J Pharm Sci. 2015;104(9):2934\u201340.","journal-title":"J Pharm Sci"},{"issue":"2","key":"770_CR21","doi-asserted-by":"crossref","DOI":"10.1111\/cmi.12646","volume":"19","author":"P Meireles","year":"2017","unstructured":"Meireles P, Sales-Dias J, Andrade CM, Mello-Vieira J, Mancio-Silva L, Simas JP, et al. GLUT1-mediated glucose uptake plays a crucial role during Plasmodium hepatic infection. Cell Microbiol. 2017;19(2):e12646.","journal-title":"Cell Microbiol"},{"issue":"1\u20132","key":"770_CR22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijpharm.2017.03.088","volume":"524","author":"H Shafi","year":"2017","unstructured":"Shafi H, Reddy DS, Khan T, Ranjan R, Srivastava A, Vaishya S, et al. Dehydroascorbate-derivatized chitosan particles for targeting antimalarial agents to infected erythrocytes. Int J Pharm. 2017;524(1\u20132):205\u201314.","journal-title":"Int J Pharm"},{"issue":"8","key":"770_CR23","first-page":"1809","volume":"46","author":"UK Baruah","year":"2018","unstructured":"Baruah UK, Gowthamarajan K, Ravisankar V, Karri VVSR, Simhadri PK, Singh V, et al. Design, characterization and antimalarial efficacy of PEGylated galactosylated nano lipid carriers of primaquine phosphate. Artif Cells Nanomed Biotechnol. 2018;46(8):1809\u201329.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"10","key":"770_CR24","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1248\/bpb.b15-00310","volume":"38","author":"T Tagami","year":"2015","unstructured":"Tagami T, Yanai H, Terada Y, Ozeki T. Evaluation of phosphatidylserine-specific peptide-conjugated liposomes using a model system of malaria-infected erythrocytes. Biol Pharm Bull. 2015;38(10):1649\u201351.","journal-title":"Biol Pharm Bull"},{"issue":"7","key":"770_CR25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3390\/pharmaceutics11070341","volume":"11","author":"A Biosca","year":"2019","unstructured":"Biosca A, Dirscherl L, Moles E, Imperial S, Fern\u00e0ndez-Busquets X. An immunoPEGliposome for targeted antimalarial combination therapy at the nanoscale. Pharmaceutics. 2019;11(7):341.","journal-title":"Pharmaceutics."},{"key":"770_CR26","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.biomaterials.2017.08.020","volume":"145","author":"E Moles","year":"2017","unstructured":"Moles E, Galiano S, Gomes A, Quiliano M, Teixeira C, Aldana I, et al. ImmunoPEGliposomes for the targeted delivery of novel lipophilic drugs to red blood cells in a falciparum malaria murine model. Biomaterials. 2017;145:178\u201391.","journal-title":"Biomaterials."},{"issue":"1s","key":"770_CR27","doi-asserted-by":"crossref","first-page":"225s","DOI":"10.18433\/jpps30117","volume":"21","author":"J Emami","year":"2018","unstructured":"Emami J, Yousefian H, Sadeghi H. Targeted nanostructured lipid carrier for brain delivery of artemisinin: design, preparation, characterization, optimization and cell toxicity. J Pharm Pharm Sci. 2018;21(1s):225s\u201341s.","journal-title":"J Pharm Pharm Sci"},{"issue":"24","key":"770_CR28","doi-asserted-by":"crossref","first-page":"6636","DOI":"10.1016\/j.biomaterials.2014.04.058","volume":"35","author":"SA Jain","year":"2014","unstructured":"Jain SA, Basu H, Prabhu PS, Soni U, Joshi MD, Mathur D, et al. Parasite impairment by targeting Plasmodium-infected RBCs using glyceryl-dilaurate nanostructured lipid carriers. Biomaterials. 2014;35(24):6636\u201345.","journal-title":"Biomaterials."},{"issue":"1","key":"770_CR29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12936-018-2302-9","volume":"17","author":"JO Muga","year":"2018","unstructured":"Muga JO, Gathirwa JW, Tukulula M, Jura WG. In vitro evaluation of chloroquine-loaded and heparin surface-functionalized solid lipid nanoparticles. Malar J. 2018;17(1):133.","journal-title":"Malar J"},{"key":"770_CR30","first-page":"25","volume":"24","author":"P Rathee","year":"2015","unstructured":"Rathee P, Dalal A, Kumar A, Ruhil M. Nanotechnology a potential tool in malarial chemotherapy-review. Nanotechnology. 2015;24:25.","journal-title":"Nanotechnology."},{"key":"770_CR31","doi-asserted-by":"crossref","unstructured":"Jain A, Gautam L, Vishwakarma N, Sharma R, Mody N, Dubey S, et al. Emergence of polymer-lipid hybrid systems in healthcare scenario. Multifunctional nanocarriers for contemporary healthcare applications: IGI Global; 2018: 448\u201370.","DOI":"10.4018\/978-1-5225-4781-5.ch017"},{"issue":"2","key":"770_CR32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1208\/s12249-019-1293-3","volume":"20","author":"N Vishwakarma","year":"2019","unstructured":"Vishwakarma N, Jain A, Sharma R, Mody N, Vyas S, Vyas SP. Lipid-based nanocarriers for lymphatic transportation. AAPS PharmSciTech. 2019;20(2):83.","journal-title":"AAPS PharmSciTech"},{"key":"770_CR33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.biomaterials.2018.02.026","volume":"163","author":"M Ismail","year":"2018","unstructured":"Ismail M, Ling L, Du Y, Yao C, Li X. Liposomes of dimeric artesunate phospholipid: a combination of dimerization and self-assembly to combat malaria. Biomaterials. 2018;163:76\u201387.","journal-title":"Biomaterials."},{"issue":"2","key":"770_CR34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7150\/thno.13653","volume":"6","author":"E Portnoy","year":"2016","unstructured":"Portnoy E, Vakruk N, Ameer Bishara MS, Magdassi S, Golenser J, Eyal S. Indocyanine green liposomes for diagnosis and therapeutic monitoring of cerebral malaria. Theranostics. 2016;6(2):167\u201376.","journal-title":"Theranostics."},{"issue":"1\u20133","key":"770_CR35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0009-3084(93)90070-J","volume":"64","author":"MJ Parnham","year":"1993","unstructured":"Parnham MJ, Wetzig H. Toxicity screening of liposomes. Chem Phys Lipids. 1993;64(1\u20133):263\u201374.","journal-title":"Chem Phys Lipids"},{"issue":"7","key":"770_CR36","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3109\/10717544.2014.885999","volume":"22","author":"K Jain","year":"2015","unstructured":"Jain K, Sood S, Gowthamarajan K. Optimization of artemether-loaded NLC for intranasal delivery using central composite design. Drug Deliv. 2015;22(7):940\u201354.","journal-title":"Drug Deliv"},{"issue":"1","key":"770_CR37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijpharm.2008.07.032","volume":"364","author":"M Joshi","year":"2008","unstructured":"Joshi M, Pathak S, Sharma S, Patravale V. Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: nanoject. Int J Pharm. 2008;364(1):119\u201326.","journal-title":"Int J Pharm"},{"issue":"1","key":"770_CR38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/10717544.2014.905883","volume":"23","author":"D Parashar","year":"2016","unstructured":"Parashar D, Aditya NP, Murthy RS. Development of artemether and lumefantrine co-loaded nanostructured lipid carriers: physicochemical characterization and in vivo antimalarial activity. Drug Deliv. 2016;23(1):123\u20139.","journal-title":"Drug Deliv"},{"issue":"1\u20132","key":"770_CR39","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ijpharm.2016.09.008","volume":"513","author":"P Prabhu","year":"2016","unstructured":"Prabhu P, Suryavanshi S, Pathak S, Patra A, Sharma S, Patravale V. Nanostructured lipid carriers of artemether\u2013lumefantrine combination for intravenous therapy of cerebral malaria. Int J Pharm. 2016;513(1\u20132):504\u201317.","journal-title":"Int J Pharm"},{"issue":"2","key":"770_CR40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/02652048.2018.1441915","volume":"35","author":"R Vanka","year":"2018","unstructured":"Vanka R, Kuppusamy G, Praveen Kumar S, Baruah UK, Karri VVSR, Pandey V, et al. Ameliorating the in vivo antimalarial efficacy of artemether using nanostructured lipid carriers. J Microencapsul. 2018;35(2):121\u201336.","journal-title":"J Microencapsul"},{"key":"770_CR41","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.trac.2015.12.016","volume":"77","author":"JEN Dolatabadi","year":"2016","unstructured":"Dolatabadi JEN, Omidi Y. Solid lipid-based nanocarriers as efficient targeted drug and gene delivery systems. TrAC Trends Anal Chem. 2016;77:100\u20138.","journal-title":"TrAC Trends Anal Chem"},{"issue":"4","key":"770_CR42","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1023\/A:1012043315093","volume":"14","author":"RH M\u00fcller","year":"1997","unstructured":"M\u00fcller RH, R\u00fchl D, Runge S, Schulze-Forster K, Mehnert W. Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant. Pharm Res. 1997;14(4):458\u201362.","journal-title":"Pharm Res"},{"issue":"5","key":"770_CR43","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1208\/s12249-014-0280-y","volume":"16","author":"L Wu","year":"2015","unstructured":"Wu L, Qiao Y, Wang L, Guo J, Wang G, He W, et al. A self-microemulsifying drug delivery system (SMEDDS) for a novel medicative compound against depression: a preparation and bioavailability study in rats. AAPS PharmSciTech. 2015;16(5):1051\u20138.","journal-title":"AAPS PharmSciTech"},{"key":"770_CR44","doi-asserted-by":"crossref","unstructured":"Piyush Chudiwal SRL. Solid self-microemulsifying drug delivery system (SMEDDS) of primaquine: bio-distribution and enhanced liver uptake. J Nanomed Nanotechnol. 2018;09(01).","DOI":"10.4172\/2157-7439.1000483"},{"issue":"4","key":"770_CR45","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4155\/tde-2016-0092","volume":"8","author":"S Bhandari","year":"2017","unstructured":"Bhandari S, Rana V, Tiwary AK. Antimalarial solid self-emulsifying system for oral use: in vitro investigation. Ther Deliv. 2017;8(4):201\u201313.","journal-title":"Ther Deliv"},{"key":"770_CR46","unstructured":"Shah A, Thakkar V, Gohel M, Baldaniya L, Gandhi T. Optimization of self micro emulsifying drug delivery system containing curcumin and artemisinin using D-optimal mixture design. 2017."},{"issue":"10","key":"770_CR47","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1080\/10837450.2016.1265554","volume":"23","author":"M Tayyab Ansari","year":"2018","unstructured":"Tayyab Ansari M, Arshad MS, Hussain A, Ahmad Z. Improvement of solubility, dissolution and stability profile of artemether solid dispersions and self emulsified solid dispersions by solvent evaporation method. Pharm Dev Technol. 2018;23(10):1007\u201315.","journal-title":"Pharm Dev Technol"},{"issue":"1\u20132","key":"770_CR48","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijpharm.2008.06.021","volume":"362","author":"SD Mandawgade","year":"2008","unstructured":"Mandawgade SD, Sharma S, Pathak S, Patravale VB. Development of SMEDDS using natural lipophile: application to \u03b2-artemether delivery. Int J Pharm. 2008;362(1\u20132):179\u201383.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"770_CR49","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijpharm.2013.07.033","volume":"455","author":"S Patil","year":"2013","unstructured":"Patil S, Suryavanshi S, Pathak S, Sharma S, Patravale V. Evaluation of novel lipid based formulation of \u03b2-artemether and lumefantrine in murine malaria model. Int J Pharm. 2013;455(1\u20132):229\u201334.","journal-title":"Int J Pharm"},{"issue":"11","key":"770_CR50","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/jphp.12795","volume":"69","author":"S Bhandari","year":"2017","unstructured":"Bhandari S, Bhandari V, Sood J, Jaswal S, Rana V, Bedi N, et al. Improved pharmacokinetic and pharmacodynamic attributes of artemether\u2013lumefantrine-loaded solid SMEDDS for oral administration. J Pharm Pharmacol. 2017;69(11):1437\u201346.","journal-title":"J Pharm Pharmacol"},{"key":"770_CR51","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijbiomac.2018.03.102","volume":"114","author":"A Kashyap","year":"2018","unstructured":"Kashyap A, Kaur R, Baldi A, Jain UK, Chandra R, Madan J. Chloroquine diphosphate bearing dextran nanoparticles augmented drug delivery and overwhelmed drug resistance in Plasmodium falciparum parasites. Int J Biol Macromol. 2018;114:161\u20138.","journal-title":"Int J Biol Macromol"},{"issue":"12","key":"770_CR52","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11095-018-2517-z","volume":"35","author":"S Mvango","year":"2018","unstructured":"Mvango S, Matshe WM, Balogun AO, Pilcher LA, Balogun MO. Nanomedicines for malaria chemotherapy: encapsulation vs. polymer therapeutics. Pharmaceutical research. 2018;35(12):237.","journal-title":"Pharmaceutical research"},{"key":"770_CR53","doi-asserted-by":"crossref","first-page":"101171","DOI":"10.1016\/j.jddst.2019.101171","volume":"53","author":"S Alven","year":"2019","unstructured":"Alven S, Aderibigbe B, Balogun MO, Matshe W, Ray SS. Polymer-drug conjugates containing antimalarial drugs and antibiotics. J Drug Deliv Sci Technol. 2019;53:101171.","journal-title":"J Drug Deliv Sci Technol"},{"key":"770_CR54","doi-asserted-by":"crossref","unstructured":"Scaria PV, Chen B, Rowe CG, Jones DS, Barnafo E, Fischer ER, et al. Protein-protein conjugate nanoparticles for malaria antigen delivery and enhanced immunogenicity. PLoS ONE. 2017;12(12):e0190312.","DOI":"10.1371\/journal.pone.0190312"},{"key":"770_CR55","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ijbiomac.2014.12.016","volume":"74","author":"S Tripathy","year":"2015","unstructured":"Tripathy S, Chattopadhyay S, Dash SK, Chowdhuri AR, Das S, Sahu SK, et al. Chitosan conjugated chloroquine: proficient to protect the induction of liver apoptosis during malaria. Int J Biol Macromol. 2015;74:585\u2013600.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"770_CR56","first-page":"33","volume":"11","author":"N Jawahar","year":"2019","unstructured":"Jawahar N, Baruah UK, Singh V. Co-delivery of chloroquine phosphate and azithromycin nanoparticles to overcome drug resistance in malaria through intracellular targeting. J Pharm Sci Res. 2019;11(1):33\u201340.","journal-title":"J Pharm Sci Res"},{"issue":"sup3","key":"770_CR57","doi-asserted-by":"crossref","first-page":"S287","DOI":"10.1080\/21691401.2018.1491481","volume":"46","author":"N Dlamini","year":"2018","unstructured":"Dlamini N, Mukaya H, Van Zyl R, Jansen van Vuuren N, Mbianda X. Carbon nanospheres conjugated bisphosphonates: synthesis, characterization and in vitro antimalarial activity. Artif Cells Nanomed Biotechnol. 2018;46(sup3):S287\u2013S96.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"32","key":"770_CR58","doi-asserted-by":"crossref","first-page":"8103","DOI":"10.1002\/chem.201800729","volume":"24","author":"T Fr\u00f6hlich","year":"2018","unstructured":"Fr\u00f6hlich T, Hahn F, Belmudes L, Leidenberger M, Friedrich O, Kappes B, et al. Synthesis of artemisinin-derived dimers, trimers and dendrimers: investigation of their antimalarial and antiviral activities including putative mechanisms of action. Chem Eur J. 2018;24(32):8103\u201313.","journal-title":"Chem Eur J"},{"key":"770_CR59","doi-asserted-by":"crossref","unstructured":"Sanches BMFE. Is prodrug design an approach to increase water solubility? Int J Pharm. 2019;568:118498.","DOI":"10.1016\/j.ijpharm.2019.118498"},{"issue":"10","key":"770_CR60","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1021\/acsinfecdis.7b00062","volume":"3","author":"L Frueh","year":"2017","unstructured":"Frueh L, Li Y, Mather MW, Li Q, Pou S, Nilsen A, et al. Alkoxycarbonate ester prodrugs of preclinical drug candidate ELQ-300 for prophylaxis and treatment of malaria. ACS Infect Dis. 2017;3(10):728\u201335.","journal-title":"ACS Infect Dis"},{"issue":"16","key":"770_CR61","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/j.bmcl.2019.06.045","volume":"29","author":"O Berger","year":"2019","unstructured":"Berger O, Ortial S, Wein S, Denoyelle S, Bressolle F, Durand T, et al. Evaluation of amidoxime derivatives as prodrug candidates of potent bis-cationic antimalarials. Bioorg Med Chem Lett. 2019;29(16):2203\u20137.","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"770_CR62","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12951-016-0179-8","volume":"14","author":"S Alam","year":"2016","unstructured":"Alam S, Panda JJ, Mukherjee TK, Chauhan VS. Short peptide based nanotubes capable of effective curcumin delivery for treating drug resistant malaria. J Nanobiotechnol. 2016;14(1):26.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"770_CR63","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12936-018-2330-5","volume":"17","author":"A Cohen","year":"2018","unstructured":"Cohen A, Zinger A, Tiberti N, Grau GE, Combes V. Differential plasma microvesicle and brain profiles of microRNA in experimental cerebral malaria. Malar J. 2018;17(1):192.","journal-title":"Malar J"},{"issue":"12","key":"770_CR64","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/s41565-018-0271-3","volume":"13","author":"W-C Huang","year":"2018","unstructured":"Huang W-C, Deng B, Lin C, Carter KA, Geng J, Razi A, et al. A malaria vaccine adjuvant based on recombinant antigen binding to liposomes. Nat Nanotechnol. 2018;13(12):1174\u201381.","journal-title":"Nat Nanotechnol"},{"issue":"1","key":"770_CR65","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s13063-019-3391-7","volume":"20","author":"M van den Berg","year":"2019","unstructured":"van den Berg M, Ogutu B, Sewankambo NK, Biller-Andorno N, Tanner M. RTS, S malaria vaccine pilot studies: addressing the human realities in large-scale clinical trials. Trials. 2019;20(1):316.","journal-title":"Trials."},{"key":"770_CR66","doi-asserted-by":"crossref","unstructured":"Gosling R, von Seidlein L. The future of the RTS, S\/AS01 malaria vaccine: an alternative development plan. PLoS Med. 2016;13(4).e1001994","DOI":"10.1371\/journal.pmed.1001994"},{"issue":"1","key":"770_CR67","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/pharmaceutics8010007","volume":"8","author":"S Tandrup Schmidt","year":"2016","unstructured":"Tandrup Schmidt S, Foged C, Smith Korsholm K, Rades T, Christensen D. Liposome-based adjuvants for subunit vaccines: formulation strategies for subunit antigens and immunostimulators. Pharmaceutics. 2016;8(1):7.","journal-title":"Pharmaceutics."}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-020-00770-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-020-00770-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-020-00770-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:44:52Z","timestamp":1744177492000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-020-00770-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,7]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["770"],"URL":"https:\/\/doi.org\/10.1007\/s13346-020-00770-z","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,7]]},"assertion":[{"value":"7 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}